日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Invention of an oral medication for cardiac Fabry disease caused by RNA mis-splicing.

发明了一种用于治疗由 RNA 剪接错误引起的法布里病的口服药物

Awaya Tomonari, Ajiro Masahiko, Kobayashi Hiroko, Sawada Teruo, Gotanda Kentoku, Noji Toshiharu, Takemoto Naohiro, Iida Kei, Saito Megumu K, Niu Dau-Ming, Hagiwara Masatoshi

Discovery and development of an oral analgesic targeting the α2B adrenoceptor

发现和开发一种靶向α2B肾上腺素受体的口服镇痛药

Toyomoto, Masayasu; Kurihara, Takashi; Nakagawa, Takayuki; Inoue, Asuka; Kimura, Ryo; Kii, Isao; Sawada, Teruo; Ogihara, Takashi; Nagayasu, Kazuki; Kishi, Takayuki; Onogi, Hiroshi; Im, Dohyun; Asada, Hidetsugu; Iwata, So; Taguchi, Jumpei; Sumida, Yuto; Yoshida, Suguru; Aoki, Junken; Hosoya, Takamitsu; Hagiwara, Masatoshi

Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts

通过单次粘贴皮肤贴剂给药于正常皮肤和皮肤疣的细胞周期蛋白依赖性激酶 9 (CDK9) 抑制剂 FIT039 的安全性和血浆浓度

Sumi, Eriko; Nomura, Takashi; Asada, Ryuta; Uozumi, Ryuji; Tada, Harue; Amino, Yoko; Sawada, Teruo; Yonezawa, Atsushi; Hagiwara, Masatoshi; Kabashima, Kenji